Mohammad Mawardi

Prof. Mohammad Mawardi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2023 in Medicine
Verified
Journal Article
Open access
HMHani Haytham Bds Mawardi
Hani Haytham Bds Mawardi
SASoulafa A. Almazrooa
Soulafa A. Almazrooa
SDSiraj Ahmed Bds Dakhil
Siraj Ahmed Bds Dakhil
AAAli Anwar Bds Aboalola
Ali Anwar Bds Aboalola
TAThamer Abdulmohsin Bds Al-Ghalib
Thamer Abdulmohsin Bds Al-Ghalib
MMMohammad Mawardi
Mohammad Mawardi
Rationale: Obesity and diabetes of different types are considered global health risks with rising prevalence. In addition to low-calorie diet and daily exercise, several treatment options have been introduced to help patient in needs. Semaglutide (Ozempic) is one popular agent, which attracted the attention of both physicians and patients due to its positive outcome in improving glucose control and weight loss. However, no reports on the effect of semaglutide use on the oral cavity and specifically xerostomia are available in the literature. We are reporting 3 cases for patients who were using semaglutide and developed secondary xerostomia. Patient concerns: Three female patients with median age of 34 (range 27–46) presented to the oral medicine clinic with chief complaint of xerostomia. All patients were overweight with a mean body mass index of 35.6 (range 35–37) and have been using semaglutide for weight loss for a mean duration of 11.3 weeks (range 6–16). Diagnoses: All 3 patients had severe dryness in the mouth with minimal frothy saliva with mean modified Schirmer test of 9 mL at 3 minutes (range 8–10 mL). Following exclusion of other possible underlying medical problems, the diagnosis of semaglutide-induced hyposalivation was given to all patients. Interventions: The patients’ management varied between discontinuation of the drug, the use of pilocarpine, and conservative symptomatic management. Outcomes: The patients resumed acceptable salivary flow. Lessons: We are reporting for the first time hyposalivation associated with the use of semaglutide. Further prospective, larger studies are warranted to confirm these findings.

31 January 2024 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
SZSamar Zailaie
Samar Zailaie
BKBasma Basim Khoja
Basma Basim Khoja
JSJumana Siddiqui
Jumana Siddiqui
MMMohammad Mawardi
Mohammad Mawardi
EHemil heaphy
emil heaphy
Consolato SergiConsolato Sergi
Consolato Sergi
Non-coding RNAs (ncRNAs) are RNA molecules that do not code for protein but play key roles in regulating cellular processes. NcRNAs globally affect gene expression in diverse physiological and pathological contexts. Functionally important ncRNAs act in chromatin modifications, in mRNA stabilization and translation, and in regulation of various signaling pathways. Non-alcoholic fatty liver disease (NAFLD) is a set of conditions caused by the accumulation of triacylglycerol in the liver. Studies of ncRNA in NAFLD are limited but have demonstrated that ncRNAs play a critical role in the pathogenesis of NAFLD. In this review, we summarize NAFLD’s pathogenesis and clinical features, discuss current treatment options, and review the involvement of ncRNAs as regulatory molecules in NAFLD and its progression to non-alcoholic steatohepatitis (NASH). In addition, we highlight signaling pathways dysregulated in NAFLD and review their crosstalk with ncRNAs. Having a thorough understanding of the disease process’s molecular mechanisms will facilitate development of highly effective diagnostic and therapeutic treatments. Such insights can also inform preventive strategies to minimize the disease’s future development.

1 March 2022 in Saudi Journal of Gastroenterology
Verified
Journal Article
Open access
BABandar Al-Judaibi
Bandar Al-Judaibi
MDM. Katherine Dokus
M. Katherine Dokus
WAWaleed Al-Hamoudi
Waleed Al-Hamoudi
DBDieter Broering
Dieter Broering
MMMohammad Mawardi
Mohammad Mawardi
SASaleh Alqahtani
Saleh Alqahtani
The field of hepatology has evolved significantly over the last two decades. Hepatology practice in Saudi Arabia (SA) was dominated by hepatitis B and C viruses but is now being overtaken by patients with non-alcoholic fatty liver disease. These patients require greater medical attention as their care is more complex compared to patients with viral hepatitis. In addition, liver transplantation (LT) has expanded significantly in SA over the last three decades. There is a necessity to increase the hepatology workforce to meet the demand in SA. The time has come to reinforce the transplant hepatology fellowship program, that was launched recently, and to develop a nurse practitioner practice model to meet these demands. In addition, SA is going through a health care reform to enhance health care delivery which may affect the financial compensation polices of various specialties including gastroenterology and hepatology. Therefore, the Saudi Association for the Study of Liver diseases and Transplantation (SASLT) established a task force to discuss the current and future demands in the hepatology workforce in SA, as well as to discuss different avenues of financial compensation for transplant hepatologists in LT centers.

19 December 2021 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
AQAbdulrahman Qatomah
Abdulrahman Qatomah
MBMajidah Bukhari
Majidah Bukhari
ECEdward Cupler
Edward Cupler
HAHosam Alardati
Hosam Alardati
MMMohammad Mawardi
Mohammad Mawardi
Introduction: Treatment of hepatitis C infection has evolved dramatically since 2011. Previous conventional therapy with interferon and ribavirin used to have a low sustained virological response rate of less than 40%. In the new direct-acting antiviral therapy era, a sustained virological response can be achieved in more than 90% of cases. Case presentation: We report a rare case of severe reversible acute rhabdomyolysis in a 31-year-old Saudi male patient with very long-chain acyl-coenzyme A dehydrogenase deficiency and chronic hepatitis C infection. The patient was clinically asymptomatic with no signs of decompensated liver disease. The patient received new direct-acting antiviral agents: sofosbuvir and daclatasvir. Fourteen days after initiation of direct-acting antiviral agents, the patient was found to have asymptomatic rhabdomyolysis. His creatine kinase peaked at 2572 IU/l, and he was treated conservatively; the direct-acting antiviral agents were discontinued and within 7 days, the patient’s creatine kinase levels normalized. Conclusion: This case highlights possible direct-acting antiviral agent-induced rhabdomyolysis in a patient with very-long-chain acyl-CoA dehydrogenase deficiency, presumably through alteration of mitochondrial membrane potential. Further studies are required to assess the possible impact and associations.

8 March 2022 in European Journal of Case Reports in Internal Medicine
Verified
Journal Article
Open access
PDF file
MGMonther Ghunaim
Monther Ghunaim
ASAli Someili
Ali Someili
MMMohammad Mawardi
Mohammad Mawardi
Candida is a rare cause of purulent pericarditis. Oesophago-pericardial fistula is an uncommon and potentially life-threatening complication of both benign and malignant oesophageal tumours. Here we report the case of 40-year-old woman who presented with symptoms and signs suggestive of acute pericarditis complicated by cardiac tamponade which required acute management with paracentesis. Pericardial fluid analysis was positive for Candida albicans. Oesophagogastroduodenoscopy was performed and revealed a small fistula in the proximal oesophagus extending into the retrocardiac space. Multiple biopsy specimens of the fistula site and oesophageal stricture were obtained. Histopathological findings were consistent with poorly differentiated squamous cell carcinoma of the oesophagus complicated by fistulation to the retrocardiac space.

2 March 2023 in International Journal of Hepatobiliary and Pancreatic Diseases
Verified
Journal Article
Open access
PDF file
MMMohammed Omer Mirghani
Mohammed Omer Mirghani
ZZZergham Zia
Zergham Zia
MMMohammad Mawardi
Mohammad Mawardi
ZAZuhoor Almansouri
Zuhoor Almansouri
NANiaz Ahmad
Niaz Ahmad
Inflammatory pseudotumor is increasingly being recognized as a definitive pathological entity affecting many organ systems and often difficult to distinguish from malignancy. We report a case of a 48-year-old female who presented with right hypochondrial pain associated with nausea and vomiting and recent weight loss. An ultrasound scan demonstrated gallstones without evidence of cholecystitis and an incidental 1.5 cm mass in the left liver lobe. A computed tomography (CT) and a magnetic resonance imaging (MRI) scan described the mass suspicious of a malignant tumour. An ultrasound-guided biopsy confirmed a benign inflammatory mass with lymphoplasmacytic infiltration staining for IgG4 and no evidence of malignancy. The patient had an elevated serum IgG4 levels. The patient was kept under surveillance. She underwent a laparoscopic cholecystectomy and at 18 months following the initial presentation the patient remains asymptomatic with stable liver lesion on ultrasound scan.